Cardiva Medical.

This can help us extend our products to more clients and enhance our degree of onsite customer support. We are very very happy to use Cardiva, stated Matthew Semler, President of Advanced Vascular Dynamics.. Cardiva Medical, Advanced Vascular Dynamics indication contract to distribute hemostasis products Cardiva Medical, Inc. Announced today that it provides signed an contract with Advanced Vascular Dynamics to distribute many products utilized for postcatheterization femoral and radial artery hemostasis in the U.S. We are delighted to provide these unique products to our customers in the US, stated John McCurdy, Vice President of Sales. McCurdy continued, The merchandise complement our Catalyst femoral artery closure program and will enable our customers to take advantage of economical options for femoral and radial artery closure.The 27.9 percent increase was powered primarily by organic growth in infusion therapies. Infusion Solutions segment revenue was $922.december 31 7 million for the twelve months ended, 2014, in comparison to $696.9 million for the same period in 2013, a 32.4 percent increase. December 31 Consolidated gross revenue for the a year finished, 2014, was $261.1 million, or 26.5 percent of revenue, in comparison to $243.6 million, or 31.7 percent of revenue, in the last year. The net upsurge in gross revenue was primarily because of organic growth. Consolidated gross profit %age %age was primarily influenced by the PBM Solutions segment and the influence of therapy blend on the Infusion Providers segment. December 31 PBM Services segment income for the a year finished, 2014 was $61.4 million, in comparison to $72.6 million for the last year period.